Adeka Corporation
[Takeda Pharmaceutical] Summary of Share Buyback and Incentive System | June 2026
Takeda Pharmaceutical plans to dispose of 71,700 shares of common stock at 4,119 JPY per share on July 17, 2026. This is part of an incentive system granted to directors, with a transfer restriction period of more than 3 years. The total disposal amount is approximately 295 million JPY.
Key Figures
- Number of shares disposed: 71,700 shares
- Disposal value: 4,119 JPY
- Total disposal amount: 295,332,300 JPY
AI要約
Overview of the Disposal
Takeda Pharmaceutical plans to dispose of 71,700 shares of common stock at 4,119 JPY per share on July 17, 2026, totaling approximately 209.53 million JPY. This is conducted as part of an incentive system for directors, with a transfer restriction period set at over 3 years. The disposal is carried out as part of a stock compensation scheme through the contribution of monetary compensation claims as physical assets, with further details and objectives of the system also described.
Background of the System and Future Outlook
This system aims to enhance corporate value and share value sharing with shareholders, with 24 eligible participants. The disposal is conducted at a fair price based on the market stock price and will be released after the transfer restriction period expires. The company is expected to continue strengthening director incentives and achieving sustainable improvements in corporate value.
Takeda Pharmaceutical Company Limited
Company overview · Stock price · Financial data · All IR
